Ledger.Open graph →
SEC Form D · filed July 27, 2017

EFFECTOR THERAPEUTICS, INC

Offering
$38.6M
Sold
$16.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

S. C. Honig · San Mateo, CADirectorMark Brown · Lubbock, TXDirectorStevan Rosenberg · Farmington Hills, MIExec · DirectorJohn L. Quinn · St. Louis, MODirectorJudith O'Brien · Boulder, CODirectorKriss E. Spradley · CHICAGO, ILExecMichael L. Bavely · St. Louis, MODirectorHenry C. Hansel · CHICAGO, ILExec · DirectorRaymond T. Kish · CHICAGO, ILExecMark L. Olson · WALNUT CREEK, CADirectorSusan R. Molina · WALNUT CREEK, CADirectorLori Greymont · Morgan Hill, CADirectorRohit Syal · Chicago, ILDirectorMichael L. Pistner · Washington, Washington, D.C.DirectorJeremy D. Barton, M.D · San Diego, CAExecMaha D. Katabi, Ph.D · San Diego, CADirectorMarkus J. Goebel, M.D., Ph.D · San Diego, CADirectorElaine D. Jones, Ph.D · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗